Ajax-Loading

Novartis AG - Total Long Term Liabilities

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Long-Term-Liabilities" stands at 30.54 Billion United States Dollars as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Total Long Term Liabilities" stands at 30.54 Billion USD. This represents a decrease of -0.29 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -4.43 percent compared to the value the year prior.
The 1 year change in percent is -4.43.
The 3 year change in percent is 3.85.
The 5 year change in percent is -29.45.
The 10 year change in percent is 9.12.

The Serie's long term average value is 32.01 Billion United States Dollars. It's latest available value, on 09/30/2025, is 4.61 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +20.75%.
The Serie's change in percent from it's maximum value, on 09/30/2020, to it's latest available value, on 09/30/2025, is -29.45%.

Total Long Term Liabilities for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Total Long Term Liabilities905,699,262,464.00
LogoJohnson & Johnson - Total Long Term Liabilities486,508,953,600.00
LogoAbbVie Inc - Total Long Term Liabilities399,570,305,024.00
LogoRoche Holding AG - Total Long Term Liabilities317,433,206,677.55
LogoAstraZeneca PLC - Total Long Term Liabilities280,205,508,085.11